Since Drp1 mediates mitochondrial mitotic fission, which is associated with accelerated cell cycle progression and increased cell proliferation, Drp1 has been proposed as a therapeutic target for PAH (Marsboom et al., 2012). Here, DNM1L is linked to pulmonary arterial hypertension.